CIRCADIAN Light has just been approved by the American Institute of Architects to offer AIA Continuing Education courses for Health, Safety, and Welfare credits.
Our first course offering is called "Circadian Lighting for Workplaces: Protecting Health and Improving Productivity." The course will educate architects and lighting designers that are specifying circadian lighting and want to gain an understanding of the key differences between the day, evening and nighttime impacts of the blue content of white light on circadian rhythms, human health and productivity.
Visit http://circadianlight.com/circadian-light-workplaces for more information, or to register.
The subject was further explored in 2007 by the International Agency for Research on Cancer (IARC) and the World Health Organization (WHO), which revealed that shift work that impacts natural circadian rhythms is “probably carcinogenic to humans.”
Further exploration of the 2007 findings revealed:
- Breast cancer increased 32% - 58% in women regularly exposed to light at night.
- Prostate cancer increased up to 200% in men regularly exposed to light at night.
- Blind women have a lower risk of breast cancer, and blind men have a lower risk of prostate cancer that is related to the degree of visual impairment.
To combat the effects of blue-rich light at night, CIRCADIAN Light introduced a DynamicBlu™ Spectrum control light solution that removes over 90% of the bioactive blue content at night to manage the risk of these types of cancers.
Click here to read the full whitepaper.
CIRCADIAN Light LED Breakthrough Verified by UL: White Light with Less than 2% Blue Content at Night
STONEHAM, MA ----- The significant health risks linked to the use of LED lights at night may have finally been solved by an innovative new LED technology. CIRCADIAN® Light’s new Night-Safe™ LEDs are the first lights verified by UL, the leading global safety certification company, to emit white light with less than 2% blue content at night. This medically-significant breakthrough addresses the growing scientific evidence that exposure at night to the 10 - 30% blue light content of conventional LEDs has a profound negative effect on many aspects of human health and performance.
Most energy efficient LEDs in the market today are rich in the blue wavelengths that at night trigger the metabolic processes involved in hypertension, atherosclerosis, and cardiovascular disease through:
1.) Disruption of the circadian system (phase shifting and circadian misalignment)
2.) Melatonin-suppression and phase shifting
3.) Activation of chronic inflammatory processes causing atherosclerosis in blood vessels
To read the full whitepaper, click here.
To combat the detrimental effects of blue rich light at night, CIRCADIAN Light introduced a Dynamic Blue Spectrum control light solution that removes over 90% of the bioactive blue content at night to manage the risk of cardiovascular disease.